ArticleAnnals of medicine and surgery (2012)2026
CRISPR-Cas9 off-target effects in urothelial gene therapy: the overlooked risk of P53 mutational signatures in bladder tissue.
Syeda Tamkeen Zahra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.